• Username (E-mail)
  • Password
Dow 19,827 0.5%  EStoxx50 3,299 0.3%  Nikkei 19,138 0.3%  EUR 1.0702 0.4% 
Nasdaq 5,555 0.3%  FTSE100 7,198 -0.1%  Yen 114.6250 0.0%  Oil 55.5 2.4% 
S&P500 2,271 0.3%  DAX 11,630 0.3%  GBP 1.2380 0.4%  Gold 1,214 -0.5% 

Pfizer share [Symbol: PFE / ISIN: US7170811035]

Realtimequote Pfizer Inc. in USD

Exchange Market
32.10
Last
1,833,797
Volume
Time 04:39 PM
01/20/2017 04:39:17 PM UTC-0500
activate push

Stock Price Pfizer Inc. in USD

Activate push
31.77 USD 0.07 USD 0.22 %
Trade Time 4:15 PM Trade Date 1/20/2017
Daily High 32.12 Open 31.73
Daily Low 31.67 Prev. Close 31.77
52-week High 37.39 Volume (Qty.) 10,232,486
52-week Low 28.25 Market Cap (USD) 194.99 B
52-week Perf.
Exchange

Analyst Opinions for Pfizer Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
01/18/17
Pfizer Goldman Sachs Group Inc.
12/19/16
Pfizer Jefferies & Company Inc.
11/11/16
Pfizer Jefferies & Company Inc.
11/01/16
Pfizer Bernstein Research
11/01/16
Pfizer Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)

Moody's Rating for Pfizer Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating A1
Rating Update AFF
Date of Rating 5/16/2016
Rating Office USA

Profile Pfizer Inc.

Company Profile
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles H. Erhart Jr. in 1849 and is headquartered in New York, NY.
pagehit

Add or Edit Instrument

Pfizer Chart - 1 Year - NYSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NYSE
  • Chart Options

Estimates for Pfizer

2015 2016e 2017e
Dividend 1.12 1.20 1.26
Dividend Yield in % 3.45 3.73 3.94
P/E Ratio 14.77 13.27 12.31
EPS 2.20 2.42 2.61

ANALYST DATA FOR Pfizer

Sell
Hold
Buy
29
30
31
32
33
34
35
36
37
38
39


Pfizer Key Figures

Market Cap (USD) 194.99 B
Free Float in % 99.94
Number of Shares (Mio.) 6,068.36
Cash Flow per Share 2.20
Book Value per Share 10.34
60-Days Volatility 27.61
P/B Ratio 3.14

Base Data Pfizer

Symbol PFE
ISIN US7170811035
Indices S&P 100, NYSE US 100, Dow Jones, S&P 500, BX Swiss - USA

About the Company Pfizer

Country USA

Pfizer Historical Prices

01/18/2017
01/18/2017 06:00:00 PM UTC-0500
31.70 6,286,774
01/17/2017
01/17/2017 06:00:00 PM UTC-0500
32.03 5,613,759
01/16/2017
01/16/2017 06:00:00 PM UTC-0500
32.06 8,704,134
01/12/2017
01/12/2017 06:00:00 PM UTC-0500
32.52 5,520,772
01/11/2017
01/11/2017 06:00:00 PM UTC-0500
32.60 8,197,077

Pfizer Peer Group

Abbott Laboratories 40.46
0.1%
Alexion Pharmaceuticals 131.97
-1.8%
AstraZeneca 43.17
-3.4%
Bayer 102.20
0.2%
Celgene 112.66
-0.8%
EVOTEC 7.43
-1.9%
Gilead Sciences 71.01
-0.8%
GlaxoSmithKline 15.45
-0.5%
Johnson & Johnson 114.15
0.0%
Merck 62.53
3.6%
Merck 102.75
0.0%
MorphoSys 48.35
-0.8%
Mylan 37.07
0.3%
Novartis 70.75
-0.4%
Pfizer 31.77
0.2%
Roche 235.80
0.0%
STADA Arzneimittel 48.06
-0.1%
Sanofi 75.69
0.1%
Teva Pharmaceutical Industries 33.23
-0.7%
Vertex Pharmaceuticals 81.37
0.6%

Similar shares with higher 1-year perf.